Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A pleomorphic xanthoastrocytomas (PXA) is a rare tumor thought to arise from a type of cell of the central nervous system known as a glial cell. These tumors likely originate from a specific type of glial cell known as an astrocyte.
As you read further, you will find general information about pleomorphic xanthoastrocytomas. If you would like to view summary information about brain tumors first, see the overview on brain tumors.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches pleomorphic xanthoastrocytomas
We hold a weekly brain tumor clinic for newly diagnosed patients currently receiving treatment. Each time you come for an appointment, you meet with every specialist on your child’s team, from your pediatric neuro-oncologist, neurologist, and neurosurgeon, to your pediatric endocrinologist, psycho-oncologist and School liaison.
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s Pediatric Brain Tumor Program offers your child the following services.
Access to one of the nation’s few dedicated pediatric brain tumor survivorship programs. This weekly clinic offers ongoing care to manage late effects caused by your child’s tumor or the treatment they received.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”